Ads
related to: target.com
Search results
Angel Reese takes indirect shot at Caitlin Clark, says people watch women's basketball for more than...
Sporting News· 2 hours agoAngel Reese accepted the villain role in the eyes of the public long ago. The Chicago Sky rookie has...
Citi cuts MongoDB stock target, maintains buy rating By Investing.com
Investing.com· 17 hours agoOn Monday, Citi has adjusted its outlook on MongoDB (NASDAQ:MDB) shares, reducing the price target...
Target’s Pride Month collection will be in fewer stores
KTLA articles via Yahoo News· 5 hours agoTarget has limited the availability of its Pride merchandise after facing intense backlash from some...
Caitlin Clark on hard fouls early in WNBA career: 'I'm trying not to let it bother me'
NBC News via Yahoo Sports· 2 hours agoBut what’s drawn so much attention are the kinds of fouls Clark has received. She said it won't...
Claudia Sheinbaum promises to govern for all. Here are the challenges she’ll face
CNN via Yahoo News· 2 hours agoClaudia Sheinbaum won a landslide victory to become the first female president of Mexico, adding to...
Cyclacel Pharmaceuticals maintains $11 target, Buy rating By Investing.com
Investing.com· 9 hours agoOn Monday, Roth/MKM maintained its Buy rating and $11.00 price target for Cyclacel Pharmaceuticals...
BofA raises Nvidia target to $1,500, sees EPS power of over $50 within 2 years By Investing.com
Investing.com· 16 hours agoBofA raises Nvidia target to $1,500, sees EPS power of over $50 within 2 years
Michael Cohen's family doxxed after Trump guilty verdict in porn star hush money case
NBC News via Yahoo News· 4 hours agoTrump supporters tried to dox jurors last week after his conviction, and they also targeted...
Biden's description of cease-fire offer ‘not accurate,’ Israeli official says
NBC News via Yahoo News· 3 hours agoPresident Joe Biden’s description of Israel’s cease-fire proposal was “not accurate,” an Israeli...
DexCom maintains $150 target amid new FDA approval By Investing.com
Investing.com· 8 hours agoOn Monday, Oppenheimer maintained its Outperform rating and $150.00 price target for DexCom...